Mirabaud
VC Fund
Geneva, Switzerland
Mirabaud is a VC fund in Geneva focused on Medical and Biotechnology. Mirabaud et Cie was founded in 1819 and is one of the oldest banks in Switzerland.[6] Family-owned and operated, the bank has played a key part in the construction and development of the Swiss financial system, helping co-found the Geneva Stock Exchange in 1857. In 1973, it pioneered the development of Swiss hedge funds.[9] In 1985, Mirabaud openedits first foreign bureau in Montréal, followed in 1990 by the reinforcement of its historical presence in London.The first Asian office was opened in Hong Kong in 1997 and one year later, the bank reinforced its presence in Switzerland by opening its first subsidiary in Zurich.In 2001, Mirabaud significantly grows its asset management teams in Geneva and London. The same year, the Group creates LPP Gestion SA to operate in the field of liability management services for pension funds.From 2003 onwards the Group continues to solidify its presence in the EU, Switzerland, and the Middle East: a new subsidiary opens in Paris, a majority stake in Jenni & Cie (Basel) is purchased in 2004, and another banking office opens in Dubai in 2007.In 2010, the Group acquires Venture Finanzas in Spain and pursues its strategic implantation by opening offices in Madrid, Barcelona, Valencia and Seville.In 2011, Mirabaud consolidates its asset management activities in Luxembourg by creating Mirabaud Asset Management (Europe) SA. A bank (Mirabaud & Cie (Europe) SA) follows in 2014. In 2015, the Group announces the acquisition of two further banking licenses in Spain and France.The group undergoes a major structural change in 2014: Mirabaud's activities become integrated into Mirabaud SCA, a Swiss corporate partnership.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mirabaud invests in
Stages Mirabaud invests in
Countries Mirabaud invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Omair Mohammad
|
|||
Yves Mirabaud
|
|||
Investment Focus
Industry
- Medical 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
- Artificial Intelligence 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Omair Mohammad
CFO
|
CFO | Total investments: 0 | Find email | |
|
Yves Mirabaud
Member of the Executive Committee and Chief Investment Officer; Senior Managing Partner
|
Member of the Executive Committee and Chief Investment Officer; Senior Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scailyte
|
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discoveryis radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers. | $6.2M / Series A / Sep 19, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Mirabaud invest in?
Mirabaud invests primarily in Medical, Biotechnology and Health Diagnostics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mirabaud?
Public channels for Mirabaud include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mirabaud?
The team at Mirabaud includes Omair Mohammad (CFO) and Yves Mirabaud (Member of the Executive Committee and Chief Investment Officer; Senior Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
